Search Results - Paul P Cook

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Unfolding $E_{11}$ by Nicolas Boulanger, Paul P. Cook, Josh A. O'Connor, Peter West

    Published in SciPost Physics (2025-05-01)
    Get full text
    Article


  2. 2

    Higher dualisations of linearised gravity and the A 1 + + + $$ {A}_1^{+++} $$ algebra by Nicolas Boulanger, Paul P. Cook, Josh A. O’Connor, Peter West

    Published in Journal of High Energy Physics (2022-12-01)
    Get full text
    Article


  3. 3

    Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1. by Ossie F Dyson, Lia R Walker, Adrian Whitehouse, Paul P Cook, Shaw M Akula

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  4. 4

    Cellular miR-6741-5p as a Prognostic Biomarker Predicting Length of Hospital Stay among COVID-19 Patients by Shaw M. Akula, John F. Williams, Lok R. Pokhrel, Anais N. Bauer, Smit Rajput, Paul P. Cook

    Published in Viruses (2022-11-01)
    Get full text
    Article


  5. 5

    MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens by Anais N. Bauer, Niska Majumdar, Frank Williams, Smit Rajput, Lok R. Pokhrel, Paul P. Cook, Shaw M. Akula

    Published in Biology (2023-10-01)
    Get full text
    Article


  6. 6

    Evaluating Molecular Mechanism of Viral Inhibition of Aerosolized Smart Nano-Enabled Antiviral Therapeutic (SNAT) on SARS-CoV-2-Infected Hamsters by Anais N. Bauer, John F. Williams, Lok R. Pokhrel, Selena Garcia, Niska Majumdar, Jeffrey B. Eells, Paul P. Cook, Shaw M. Akula

    Published in Toxics (2024-07-01)
    Get full text
    Article


  7. 7

    Erratum by Rosie S. Jones, Patricia S. Smith, Paul H. Berg, Amparo de la Peña, Paul P. Cook, Imad Shawa, Kathleen M. Kioussopoulos, Yu Hu, Robert J. Schott

    Get full text
    Article


  8. 8

    Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Pres... by Rosie S. Jones, Patricia S. Smith, Paul H. Berg, Amparo de la Peña, Paul P. Cook, Imad Shawa, Kathleen M. Kioussopoulos, Yu Hu, Robert J. Schott

    Get full text
    Article


  9. 9

    Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI by Colleen S. Kraft, Matthew Sims, Michael Silverman, Thomas J. Louie, Paul Feuerstadt, Edward S. Huang, Sahil Khanna, Charles S. Berenson, Elaine E. L. Wang, Stuart H. Cohen, Louis Korman, Christine Lee, Colleen R. Kelly, Alberto Odio, Paul P. Cook, Bret Lashner, Mayur Ramesh, Princy Kumar, Ananya De, Asli Memisoglu, David A. Lombardi, Brooke R. Hasson, Barbara H. McGovern, Lisa von Moltke, Darrell S. Pardi, on behalf of the ECOSPOR III and ECOSPOR IV investigators

    Published in Infectious Diseases and Therapy (2024-06-01)
    Get full text
    Article


  10. 10

    Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI by Colleen S. Kraft, Matthew Sims, Michael Silverman, Thomas J. Louie, Paul Feuerstadt, Edward S. Huang, Sahil Khanna, Charles S. Berenson, Elaine E. L. Wang, Stuart H. Cohen, Louis Korman, Christine Lee, Colleen R. Kelly, Alberto Odio, Paul P. Cook, Bret Lashner, Mayur Ramesh, Princy Kumar, Ananya De, Asli Memisoglu, David A. Lombardi, Brooke R. Hasson, Barbara H. McGovern, Lisa von Moltke, Darrell S. Pardi, on behalf of the ECOSPOR III and ECOSPOR IV investigators

    Published in Infectious Diseases and Therapy (2024-08-01)
    Get full text
    Article


Search Tools: